Physician

Uzma Ali, MBBS

According to 2025 Medicare claims, Uzma Ali, MBBS (NPI: 1346254430) practices medical oncology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Anoka, MN. This provider's primary affiliated billing organization is MINNESOTA ONCOLOGY HEMATOLOGY, PA (NPI: 1528035995; TIN: 411793418) and primary practice location at 55432-2866.

Ali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 396 traditional Medicare patients, billed 116,111 HCPCS/CPT codes, and received $1,957,755 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,693 prescription claims across 297 beneficiaries totaling $5,173,604 in drug costs, led by Imbruvica (Ibrutinib). 2023 DME data shows 22 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $713,646 to $1,957,755. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $715,642 to $5,173,604. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $6,155 to $2,650.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2015 Medicare payment: $713,646 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $552,152 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $710,354 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $658,287 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,970,831 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,432,519 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,908,762 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,552,376 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,377,145 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,957,755 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201525962,309$713,646
201626044,935$552,152
201730754,438$710,354
201832753,248$658,287
2019511161,804$1,970,831
2020447176,712$2,432,519
2021454149,925$1,908,762
202238999,010$1,552,376
2023435148,287$2,377,145
2024396116,111$1,957,755

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.6M$5.2M2015 Drug cost: $715,642 (USD; Tot_Drug_Cst)2016 Drug cost: $803,519 (USD; Tot_Drug_Cst)2017 Drug cost: $818,993 (USD; Tot_Drug_Cst)2018 Drug cost: $1,923,360 (USD; Tot_Drug_Cst)2019 Drug cost: $2,627,939 (USD; Tot_Drug_Cst)2020 Drug cost: $3,413,743 (USD; Tot_Drug_Cst)2021 Drug cost: $3,872,696 (USD; Tot_Drug_Cst)2022 Drug cost: $3,673,250 (USD; Tot_Drug_Cst)2023 Drug cost: $3,943,408 (USD; Tot_Drug_Cst)2024 Drug cost: $5,173,604 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151621,025$715,642
20161881,045$803,519
20172141,121$818,993
20182411,426$1,923,360
20192571,580$2,627,939
20202631,681$3,413,743
20212531,475$3,872,696
20222341,230$3,673,250
20232621,484$3,943,408
20242971,693$5,173,604

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$9.1K$18K2015 Medicare payment: $18,270 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $13,280 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $896 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,230 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $5,383 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $735 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,212 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R146$18,270
2016N/R36$13,280
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R17$896
2020N/R15$2,230
2021N/R67$5,383
2022N/R14$735
2023N/R22$1,212
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less91253$107
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more104196$98
80053Blood test, comprehensive group of blood chemicals128362$10
36415Insertion of needle into vein for collection of blood sample146510$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count132526$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib29820$824,646
RevlimidLenalidomide391,085$777,528
CalquenceAcalabrutinib Maleate511,530$643,439
IbrancePalbociclib30840$472,359
PomalystPomalidomide21588$463,350

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Uzma Ali, MBBS?

Tedicare shows public-source Medicare data for Uzma Ali, MBBS (NPI 1346254430), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Uzma Ali, MBBS have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Uzma Ali, MBBS?

Uzma Ali, MBBS is linked to MINNESOTA ONCOLOGY HEMATOLOGY, PA (billing NPI 1528035995) in the available physician profile data.

Does Uzma Ali, MBBS have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.